XML 20 R9.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statement of Cash Flows (unaudited)
$ in Millions
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
USD ($)
Dec. 31, 2024
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Operating activities            
Net income $ 398   $ 198 $ 525 $ 560  
Reconciliation of net income to net cash provided by operating activities            
Depreciation and amortization       1,028 864  
Goodwill impairment 0   0 305 0 $ 118
Provision for credit losses 415   645 990 1,609  
Loss (gain) on mortgage and automotive loans, net 3   (6) 6 (18)  
Other loss (gain) on investments, net (56)   (74) 382 (96)  
Originations and purchases of loans held-for-sale       (1,392) (1,413)  
Proceeds from sales and repayments of loans held-for-sale       1,505 1,862  
Net change in            
Deferred income taxes       (366) (218)  
Interest payable       207 567  
Other assets       (227) (181)  
Other liabilities       10 (130)  
Other, net       116 171  
Net cash provided by operating activities       3,089 3,577  
Investing activities            
Purchases of equity securities       (613) (630)  
Proceeds from sales of equity securities       735 680  
Purchases of available-for-sale securities       (4,970) (462)  
Proceeds from sales of available-for-sale securities       4,216 134  
Proceeds from repayments of available-for-sale securities       1,413 1,450  
Purchases of held-to-maturity securities       (412) 0  
Proceeds from repayments of held-to-maturity securities       388 360  
Purchases of finance receivables and loans held-for-investment       (3,580) (2,612)  
Proceeds from sales of finance receivables and loans initially held-for-investment       59 1,190  
Originations and repayments of finance receivables and loans initially held-for-investment and other, net       1,306 1,526  
Purchases of operating lease assets       (3,384) (2,543)  
Disposals of operating lease assets       2,108 3,113  
Proceeds from sale of operation or business unit, net       2,412 1,956  
Net change in nonmarketable equity investments       (71) 84  
Other, net       (420) (461)  
Net cash (used in) provided by investing activities       (813) 3,785  
Financing activities            
Net change in short-term borrowings       2,254 (1,526)  
Net decrease in deposits       (3,099) (2,757)  
Proceeds from issuance of long-term debt       2,571 2,866  
Repayments of long-term debt       (3,379) (3,683)  
Repurchases of common stock       (36) (31)  
Common stock dividends paid       (285) (280)  
Preferred stock dividends paid       (83) (83)  
Net cash used in financing activities       (2,057) (5,494)  
Effect of exchange-rate changes on cash and cash equivalents and restricted cash       5 (3)  
Net increase in cash and cash equivalents and restricted cash       224 1,865  
Cash and cash equivalents and restricted cash at beginning of year   $ 9,304   11,380 7,439 7,439
Cash and cash equivalents and restricted cash at September 30, 11,604 11,380 9,304 11,604 9,304 11,380
Cash paid for            
Interest       4,572 5,043  
Income taxes       161 94  
Noncash items            
Held-to-maturity securities received in consideration for loans sold       0 56  
Loans held-for-sale transferred to finance receivables and loans held-for-investment       19 28  
Finance receivables and loans held-for-investment transferred to loans held-for-sale       2,404 1,729  
Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]            
Cash and cash equivalents on the Condensed Consolidated Balance Sheet 10,246 10,292 8,616 10,246 8,616 10,292
Restricted cash and cash equivalents and restricted cash held for securitization trusts included in other assets on the Condensed Consolidated Balance Sheet 1,358 [1]   688 [1] 1,358 [1] 688 [1]  
Total cash and cash equivalents and restricted cash in the Condensed Consolidated Statement of Cash Flows $ 11,604 $ 11,380 $ 9,304 $ 11,604 $ 9,304 $ 11,380
[1] Refer to Note 11 for additional details describing the nature of restricted cash and cash equivalent balances.